Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Heptane SCHEMBL9263200 | 1.00 | TSHR (0.61) | TSHRTHRBSPHK1LMNAALDH1A1 | |
| Isopropyl Alcohol SCHEMBL28547099 | 1.00 | TSHR (0.61) | TSHRTHRBSPHK1LMNAALDH1A1 | |
| Heptane SCHEMBL29253938 | 1.00 | TSHR (0.61) | TSHRTHRBSPHK1LMNAALDH1A1 | |
| Dodecane SCHEMBL15048503 | 1.00 | TSHR (0.61) | TSHRTHRBSPHK1LMNAALDH1A1 | |
| Decane SCHEMBL11321882 | 1.00 | TSHR (0.61) | TSHRTHRBSPHK1LMNAALDH1A1 | |
| Octane SCHEMBL28183932 | 1.00 | TSHR (0.61) | TSHRTHRBSPHK1LMNAALDH1A1 | |
| Heptane SCHEMBL652606 | 0.96 | TSHR (0.57) | TSHRTHRBSPHK1LMNAALDH1A1 | |
| Heptane SCHEMBL13720875 | 0.96 | TSHR (0.57) | TSHRTHRBSPHK1LMNAALDH1A1 | |
| Heptane SCHEMBL1399518 | 0.96 | TSHR (0.57) | TSHRTHRBSPHK1LMNAALDH1A1 | |
| Hexane SCHEMBL23068705 | 0.96 | TSHR (0.54) | TSHRTHRBSPHK1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1942 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240109848-A1 | PROCESS FOR THE PREPARATION OF IMIDAZOBENZODIAZEPINES | ODH IP Corp. (US) | 2024-04-04 | — | — | US | claimed |
| WO-2024046279-A1 | POLYMORPH OF MAO-B INHIBITOR PRODRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 广州市恒诺康医药科技有限公司 | 2024-03-07 | — | — | WO | claimed |
| CN-114609273-B | Based on solid phase extraction-UPC 2 Method for separating and determining florfenicol enantiomer and metabolite thereof in pork | 杭州海关技术中心 | 2023-07-18 | — | — | CN | claimed |
| CN-114609276-B | Method for determining florfenicol enantiomer and metabolite thereof in fish meat by ultra-high performance synthetic phase chromatography | 杭州海关技术中心 | 2023-05-26 | — | — | CN | claimed |
| CN-115494190-A | Method for simultaneously determining residual quantity of triadimefon and triadimenol enantiomer serving as metabolite of triadimefon in fruit and vegetable paste | 浙江省检验检疫科学技术研究院 | 2022-12-20 | — | — | CN | claimed |
| CN-110554107-B | Method for analyzing triglyceride components in edible oil by high performance liquid chromatography-mass spectrometry | 上海应用技术大学 | 2022-06-10 | — | — | CN | claimed |
| CN-114609273-A | Based on solid phase extraction-UPC2Method for separating and determining florfenicol enantiomer and metabolite thereof in pork | 杭州海关技术中心 | 2022-06-10 | — | — | CN | claimed |
| CN-114609276-A | Method for determining florfenicol enantiomer and metabolite thereof in fish through ultra-high performance synthesis phase chromatography | 杭州海关技术中心 | 2022-06-10 | — | — | CN | claimed |
| CN-110554106-B | Identification method for adulteration of vegetable oil | 上海应用技术大学 | 2022-05-31 | — | — | CN | claimed |
| CN-114436790-A | Synthesis method of 6-methoxy-1-tetralone | 浙江仙居君业药业有限公司 | 2022-05-06 | — | — | CN | claimed |
| US-20020042927-A1 | Meiosis activating sterol augments implantation rate | NOVO NORDISK A/S (DK) | 2002-04-11 | — | — | US | claimed |
| EP-1157096-A2 | CULTURE MEDIUM COMPRISING MEIOSIS ACTIVATING STEROLS (MAS) AND METHOD FOR INVITRO FERTILISATION | NOVO NORDISK A/S (DK) | 2001-11-28 | — | — | EP | claimed |
| US-20010014745-A1 | PROCESS FOR THE PREPARTION OF 6-(ARYLCARBONYL)-4-OXIMO-DIHYDROBENZOTHIOPYRAN HERBICIDES AND INTERMEDIATES USEFUL THEREIN | DOEHNER JR ROBERT FRANCIS (US) | 2001-08-16 | — | — | US | claimed |
| EP-0915092-B1 | Process for the preparation of 6-(arylcarbonyl)-4-oximo-dihydrobenzothiopyran herbicides and intermediates useful therein | BASF AG (DE) | 2001-06-13 | — | — | EP | claimed |
| WO-2000052142-A2 | CULTURE MEDIUM COMPRISING MEIOSIS ACTIVATING STEROLS (MAS) AND METHOD FOR IN VITRO FERTILISATION | NOVO NORDISK A/S (DK) | 2000-09-08 | — | — | WO | claimed |
| US-6008402-A | REACTING CYCLOHEXADIENECARBOXYLATE-4-ONE COMPOUND WITH A BETA MERCAPTOPROPIONIC ACID TO GIVE THIOENOL, CYCLODEHYDRATING THE THIOENOL | AMERICAN CYANAMID COMPANY (US) | 1999-12-28 | — | — | US | claimed |
| EP-0915898-A1 | CRYSTAL FORM I OF CLARITHROMYCIN | Abbott Laboratories (US) | 1999-05-19 | — | — | EP | claimed |
| EP-0915092-A1 | Process for the preparation of 6-(arylcarbonyl)-4-oximo-dihydrobenzothiopyran herbicides and intermediates useful therein | American Cyanamid Company (US) | 1999-05-12 | — | — | EP | claimed |
| US-5858986-A | CONVERTING ERYTHROMYCIN A INTO ITS 9-OXIME DERIVATIVE; PROTECTING 2' AND 4? HYDROXY GROUPS; METHYLATION; DEPROTECTING AND DEOXIMATING; TREATING WITH SOLVENT; ISOLATION; DRYING | ABBOTT LABORATORIES (US) | 1999-01-12 | — | — | US | claimed |
| WO-1998004573-A1 | CRYSTAL FORM I OF CLARITHROMYCIN | ABBOTT LABORATORIES (US) | 1998-02-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109848-A1 | PROCESS FOR THE PREPARATION OF IMIDAZOBENZODIAZEPINES | CYP3A4, CYP3A5, CYP3A7 | TSHR 962/4885THRB 1803/4885SPHK1 3279/4885 |
| US-20010014745-A1 | PROCESS FOR THE PREPARTION OF 6-(ARYLCARBONYL)-4-OXIMO-DIHYDROBENZOTHIOPYRAN HERBICIDES AND INTERMEDIATES USEFUL THEREIN | DDT, CYP4X1, CYP2B6 | TSHR 1654/4885THRB 1736/4885SPHK1 2263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.